Nanomaterials for mRNA‐based therapeutics: Challenges and opportunities
Open Access
- 29 January 2023
- journal article
- review article
- Published by Wiley in Bioengineering & Translational Medicine
- Vol. 8 (3) , e10492
Abstract
Messenger RNA (mRNA) holds great potential in developing immunotherapy, protein replacement, and genome editing. In general, mRNA does not have the risk of being incorporated into the host genome and does not need to enter the nucleus for transfection, and it can be expressed even in nondividing cells. Therefore, mRNA‐based therapeutics provide a promising strategy for clinical treatment. However, the efficient and safe delivery of mRNA remains a crucial constraint for the clinical application of mRNA therapeutics. Although the stability and tolerability of mRNA can be enhanced by directly retouching the mRNA structure, there is still an urgent need to improve the delivery of mRNA. Recently, significant progress has been made in nanobiotechnology, providing tools for developing mRNA nanocarriers. Nano‐drug delivery system is directly used for loading, protecting, and releasing mRNA in the biological microenvironment and can be used to stimulate the translation of mRNA to develop effective intervention strategies. In the present review, we summarized the concept of emerging nanomaterials for mRNA delivery and the latest progress in enhancing the function of mRNA, primarily focusing on the role of exosomes in mRNA delivery. Moreover, we outlined its clinical applications so far. Finally, the key obstacles of mRNA nanocarriers are emphasized, and promising strategies to overcome these obstacles are proposed. Collectively, nano‐design materials exert functions for specific mRNA applications, provide new perception for next‐generation nanomaterials, and thus revolution of mRNA technology.Keywords
Funding Information
- Basic and Applied Basic Research Foundation of Guangdong Province (2020A1515011581)
This publication has 224 references indexed in Scilit:
- Inhibition of Xenograft Tumor Growth by Gold Nanoparticle-DNA Oligonucleotide Conjugates-Assisted Delivery of BAX mRNAPLOS ONE, 2013
- RNA-Guided Human Genome Engineering via Cas9Science, 2013
- Modified Foxp3 mRNA protects against asthma through an IL-10–dependent mechanismJournal of Clinical Investigation, 2013
- Genetically Engineered Microvesicles Carrying Suicide mRNA/Protein Inhibit Schwannoma Tumor GrowthMolecular Therapy, 2013
- Genetic engineering of human pluripotent cells using TALE nucleasesNature Biotechnology, 2011
- Control of poly(A) tail lengthWIREs RNA, 2010
- mRNA transfection of cervical carcinoma and mesenchymal stem cells mediated by cationic carriersJournal of Controlled Release, 2010
- Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological TargetsCell, 2009
- Vaccination greatly reduces disease, disability, death and inequity worldwide2008
- Progress and problems with the use of viral vectors for gene therapyNature Reviews Genetics, 2003